Josh Distler
President bij Oak Hill Bio Corp.
Profiel
Josh Distler is the founder of Apaxel Life Sciences GmbH.
He is currently the Co-President, Chief Financial Officer & Director at Oak Hill Bio Corp.
Prior to this, he worked as a Director at Schrödinger, Inc. and as the Managing Director of Portfolio Research at Magnitude Capital LLC (Investment Management) from 2013 to 2019.
He also served as an Independent Director at JATT Acquisition Corp.
and as the COO-Global Private Investing at D.E.
Shaw & Co. LLC.
Additionally, he held the position of Chief Operating Officer at Attenuon, LLC.
Mr. Distler completed his undergraduate studies at Harvard University and obtained a graduate degree from Yale Law School.
Actieve functies van Josh Distler
| Bedrijven | Functie | Begin |
|---|---|---|
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | President | - |
Eerdere bekende functies van Josh Distler
| Bedrijven | Functie | Einde |
|---|---|---|
| JATT ACQUISITION CORP | Directeur/Bestuurslid | 24-09-2021 |
Magnitude Capital LLC (Investment Management)
 Magnitude Capital LLC (Investment Management) Investment ManagersFinance Magnitude Capital LLC (Magnitude) is an independent investment adviser and Fund of Hedge Funds Manager headquartered in New York City. Magnitude was founded in 2002 and builds and manages global, multi-strategy hedge-fund portfolios and related vehicles. | Analyst-Equity | 01-02-2019 |
| Apaxel Life Sciences GmbH | Oprichter | - |
| Attenuon, LLC | Operationeel Directeur | - |
D.E. Shaw & Co. LLC
 D.E. Shaw & Co. LLC Investment ManagersFinance Part of D.E. Shaw & Co. II, Inc., D.E. Shaw & Co. LLC is a company that provides investment advice. The company is based in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Josh Distler
| Harvard University | Undergraduate Degree |
| Yale Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCHRÖDINGER, INC. | Technology Services |
| Bedrijven in privébezit | 6 |
|---|---|
D.E. Shaw & Co. LLC
D.E. Shaw & Co. LLC Investment ManagersFinance Part of D.E. Shaw & Co. II, Inc., D.E. Shaw & Co. LLC is a company that provides investment advice. The company is based in New York, NY. | Finance |
| Attenuon, LLC | |
Magnitude Capital LLC (Investment Management)
Magnitude Capital LLC (Investment Management) Investment ManagersFinance Magnitude Capital LLC (Magnitude) is an independent investment adviser and Fund of Hedge Funds Manager headquartered in New York City. Magnitude was founded in 2002 and builds and manages global, multi-strategy hedge-fund portfolios and related vehicles. | Finance |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance JATT Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Someit Sidhu on March 10, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
| Apaxel Life Sciences GmbH | |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
